Beacon Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
94,815
-4,016
-4% -$105K 0.21% 109
2026
Q1
$2.78M Sell
98,831
-7,555
-7% -$201K 0.28% 90
2025
Q4
$2.65M Sell
106,386
-7,380
-6% -$186K 0.26% 91
2025
Q3
$2.9M Sell
113,766
-19,354
-15% -$478K 0.29% 87
2025
Q2
$3.23M Sell
133,120
-13,403
-9% -$313K 0.34% 78
2025
Q1
$3.71M Sell
146,523
-10,711
-7% -$280K 0.41% 66
2024
Q4
$4.17M Sell
157,234
-10,028
-6% -$272K 0.45% 58
2024
Q3
$4.84M Sell
167,262
-4,165
-2% -$121K 0.52% 54
2024
Q2
$4.8M Sell
171,427
-6,310
-4% -$174K 0.55% 49
2024
Q1
$4.93M Buy
177,737
+151,056
+566% +$4.19M 0.57% 46
2023
Q4
$768K Sell
26,681
-2,148
-7% -$64.9K 0.09% 169
2023
Q3
$1.02M Sell
28,829
-723
-2% -$25.6K 0.14% 133
2023
Q2
$1.07M Buy
29,552
+465
+2% +$18.1K 0.14% 130
2023
Q1
$1.21M Sell
29,087
-332
-1% -$14.3K 0.17% 122
2022
Q4
$1.51M Buy
29,419
+165
+0.6% +$7.91K 0.21% 113
2022
Q3
$1.29M Sell
29,254
-135
-0.5% -$6.56K 0.2% 110
2022
Q2
$1.49M Sell
29,389
-588
-2% -$30K 0.22% 104
2022
Q1
$1.57M Sell
29,977
-140,283
-82% -$7.28M 0.21% 113
2021
Q4
$9.64M Sell
170,260
-1,951
-1% -$96.7K 1.25% 18
2021
Q3
$7.5M Buy
172,211
+460
+0.3% +$20.4K 1.01% 27
2021
Q2
$7.05M Sell
171,751
-3,378
-2% -$131K 1% 25
2021
Q1
$6.45M Hold
175,129
1.01% 24
2020
Q4
$6.45M Sell
175,129
-8,210
-4% -$301K 1.01% 25
2020
Q3
$6.38M Sell
183,339
-4,797
-3% -$168K 1.14% 19
2020
Q2
$5.83M Buy
188,136
+24,817
+15% +$843K 1.12% 22
2020
Q1
$5.06M Buy
163,319
+12,310
+8% +$419K 1.11% 23
2019
Q4
$5.61M Buy
151,009
+4,437
+3% +$158K 0.7% 35
2019
Q3
$5.04M Sell
146,572
-355
-0.2% -$12.9K 0.86% 36
2019
Q2
$6.04M Sell
146,927
-268
-0.2% -$10.6K 1.03% 30
2019
Q1
$5.93K Sell
147,195
-569
-0.4% -$22.8K 0.97% 28
2018
Q4
$6.02M Sell
147,764
-136,349
-48% -$5.66M 1.13% 27
2018
Q3
$11.9M Sell
284,113
-16,737
-6% -$644K 2% 8
2018
Q2
$10.4M Sell
300,850
-3,104
-1% -$106K 1.75% 10
2018
Q1
$10.2M Sell
303,954
-8,226
-3% -$283K 1.75% 11
2017
Q4
$10.7M Sell
312,180
-9,685
-3% -$330K 1.87% 11
2017
Q3
$10.9M Buy
321,865
+81,479
+34% +$2.62M 1.97% 9
2017
Q2
$7.67M Buy
240,386
+5,299
+2% +$167K 1.46% 28
2017
Q1
$7.66M Buy
235,087
+732
+0.3% +$23.1K 1.46% 28
2016
Q4
$7.22M Buy
234,355
+7,629
+3% +$233K 1.47% 29
2016
Q3
$7.17M Buy
226,726
+209,118
+1,188% +$6.99M 1.51% 25
2016
Q2
$585K Buy
17,608
+315
+2% +$10.1K 0.13% 106
2016
Q1
$493K Sell
17,293
-392
-2% -$11.2K 0.11% 119
2015
Q4
$549K Buy
17,685
+956
+6% +$30.1K 0.13% 105
2015
Q3
$492K Sell
16,729
-4,653
-22% -$149K 0.12% 108
2015
Q2
$681K Sell
21,382
-8,494
-28% -$277K 0.15% 89
2015
Q1
$993K Buy
29,876
+4,187
+16% +$133K 0.22% 74
2014
Q4
$764K Buy
25,689
+1,911
+8% +$54.8K 0.16% 92
2014
Q3
$671K Buy
23,778
+2,222
+10% +$62.4K 0.15% 99
2014
Q2
$607K Sell
21,556
-8,065
-27% -$230K 0.13% 102
2014
Q1
$896K Sell
29,621
-1,513
-5% -$45.1K 0.18% 84
2013
Q4
$907K Sell
31,134
-4,806
-13% -$140K 0.17% 94
2013
Q3
$985K Buy
+35,940
New +$978K 0.21% 89

Other funds holding PFE

Beacon Financial Group's PFE Position: Q2 2026 in Review

Beacon Financial Group reduced its Pfizer (PFE) stake by 4.1% in Q2 2026, selling an estimated $105K and leaving 94,815 shares worth $2.28M. The position accounts for 0.21% of the portfolio, ranked #109.

Beacon Financial Group first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q3 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Beacon Financial Group held 94,815 shares of Pfizer worth $2.28M as of Q2 2026.
  • Beacon Financial Group sold 4,016 Pfizer shares in Q2 2026, an estimated $105K.
  • Pfizer made up 0.21% of Beacon Financial Group's portfolio in Q2 2026, its #109 holding.
  • Beacon Financial Group first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
  • Beacon Financial Group's Pfizer position peaked at $11.9M in Q3 2018.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.